Ensuring radical surgery for liver malignancies
https://doi.org/10.16931/1995-5464.20184118-125
Abstract
Despite significant progress in experimental oncology over the last few years, surgical approach is still gold standard in patients with different types of cancer including liver malignancies. Development of surgical techniques significantly improved immediate results of treatment. However, it should be noted that postoperative life expectancy is under much less attention in surgical practice. Different ways to achieve radical operations and improve long-term outcomes are reviewed in the article.
About the Authors
Yu. I. Patyutko
Blokhin National Medical Cancer Research Center of Healthcare Ministry of Russia
Russian Federation
Russian Federation
Yury I. Patyutko - Doct. of Med. Sci., Chief Researcher of the Department of Hepato-pancreatobiliary Surgery.
23, Kashirskoe shosse, Moscow, 115478
D. V. Podluzhny
Blokhin National Medical Cancer Research Center of Healthcare Ministry of Russia
Russian Federation
Russian Federation
Danil V. Podluzhny - Cand. of Med. Sci., Head of the Department of Hepato-pancreatobiliary Surgery.
23, Kashirskoe shosse, Moscow, 115478
N. E. Kudashkin
Blokhin National Medical Cancer Research Center of Healthcare Ministry of Russia
Russian Federation
Russian Federation
Nikolay E. Kudashkin - Cand. of Med. Sci., Senior Researcher of the Department of Hepato-pancreatobiliary Surgery.
23, Kashirskoe shosse, Moscow, 115478
A. N. Polyakov
Blokhin National Medical Cancer Research Center of Healthcare Ministry of Russia
Russian Federation
Russian Federation
Aleksandr N. Polyakov - Cand. of Med. Sci., Researcher of the Department of Hepato-pancreatobiliary Surgery.
23, Kashirskoe shosse, Moscow, 115478
E. V. Gluhov
Blokhin National Medical Cancer Research Center of Healthcare Ministry of Russia
Russian Federation
Russian Federation
Evgeniy V. Gluhov - Cand. of Med. Sci., Surgical Oncologist of the Department of Hepato-pancreatobiliary Surgery.
23, Kashirskoe shosse, Moscow, 115478
O. N. Solovieva
Blokhin National Medical Cancer Research Center of Healthcare Ministry of Russia
Russian Federation
Russian Federation
Olesya N. Solovieva - Oncologist of the Department of Hepato-pancreatobiliary Surgery, Blokhin National Medical Cancer Research Center of Healthcare Ministry of Russia.
23, Kashirskoe shosse, Moscow, 115478
Z. A. Dudaev
Blokhin National Medical Cancer Research Center of Healthcare Ministry of Russia
Russian Federation
Russian Federation
Zaurbek A. Dudaev - Resident of the Department of Hepato-pancreatobiliary Surgery.
23, Kashirskoe shosse, Moscow, 115478, Phone: +7-925-529-06-06
References
1. Simillis C., Li T., Vaughan J., Becker L.A., Davidson B.R., Gurusamy K.S. Methods to decrease blood loss during liver resection: a network meta-analysis. Cochrane Database Syst. Rev. 2014; (4): CD010683. DOI: 10.1002/14651858.CD010683.pub2. Update in: Cochrane Database Syst. Rev. 2016; 31 (10): CD010683.
2. Azoulay D., Lim C., Salloum C., Andreani P., Maggi U., Bartelmaos T., Castaing D., Pascal G., Fesuy F. Complex liver resection using standard total vascular exclusion, venovenous bypass, and in situ hypothermic portal perfusion: an audit of 77 consecutive cases. Ann. Surg. 2015; 262 (1): 93-104. DOI: 10.1097/SLA.0000000000000787.
3. Madhavan S., Shelat V.G., Soong S.L., Woon W.WL., Huey T., Chan Y.H., Junnarkar S.P. Langenbecks predicting morbidity of liver resection. Arch. Surg. 2018; 403 (3): 359-369. DOI: 10.1007/s00423-018-1656-3. PMID: 29417211.
4. Patyutko Yu.I., Badalyan Kh.V., Vul'fova Yu.I., Tupitsyn N.N. Prevention of tumor cells release into bloodstream during liver resections. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery. 2006; 11 (2): 7-11. (In Russian)
5. Kokudo N., Miki Y., Sugai S., Yanagisawa A., Kato Y., Sakamoto Y., Yamamoto J., Yamaguchi T., Muto T., Makuuchi M. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch. Surg. 2002; 137 (7): 833-840. PMID: 12093342 DOI: 10.1001/archsurg.137.7.833.
6. Sadot E., Groot Koerkamp B., Leal J.N., Shia J., Gonen M., Allen P.J., DeMatteo R.P., Kingham T.P., Kemeny N., Blumgart L.H., Jarnagin W.R., D'Angelica M.I. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? Ann. Surg. 2015; 262 (3): 476-485; discussion 483-485. DOI: 10.1097/SLA.0000000000001427.
7. Muratore A., Ribero D., Zimmitti G., Mellano A., Langella S., Capussotti L. Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann. Surg. Oncol. 2010; 17 (5): 1324-1329. DOI: 10.1245/s10434-009-0770-4.
8. Tsukamoto S., Kinugasa Y., Yamaguchi T., Shiomi A. Survival after resection of liver and lung colorectal metastases in the era of modern multidisciplinary therapy. Int. J. Colorectal. Dis. 2014; 29 (1): 81-87. DOI: 10.1007/s00384-013-1752-3.
9. Mise Y., Mehran R.J., Aloia T.A., Vauthey J.N. Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases. Surgery. 2014; 156 (5): 1197-1203. DOI: 10.1016/j.surg.2014.04.050.
10. Andres A., Mentha G., Adam R., Gerstel E., Skipenko O.G., Barroso E., Lopez-Ben S., Hubert C., Majno P.E., Toso C. Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases. Br. J. Surg. 2015; 102 (6): 691-699. DOI: 10.1002/bjs.9783.
11. Mamontov K.G., Patyutko Yu.I., Kotel'nikov A.G., Lazarev A.F., Ponomarenko А.А. Choice of treatment for resectable colorectal cancer liver metastases with unfavorable prognosis. Moskovskij khirurgicheskijzhurnal. 2014; 35 (1): 5-12. (In Russian)
12. Patyutko Y.I., Polyakov A.N., Kotel'nikov A.G., Sagaydak I.V., Gahramanov A.D., Chistyakova O.V., Moroz E.A. Surgical and combined treatment of patients with cholangiocellular carcinoma. Pirogov Russian Journal of Surgery = Khirurgiya. Zhurnal imeniN.I. Pirogova. 2015; (11): 11-24. DOI: 10.17116/hirurgia20151111-24. (In Russian)
13. Bruix J., Takayama T., Mazzaferro V., Chau G.Y., Yang J., Kudo M. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): A phase 3, randomised, doubleblind, placebo-controlled trial. Lancet Oncol. Elsevier Ltd, 2015; 16 (13): 1344-1354.
14. Podluzhny D.V., Solov'eva O.N., Kotelnikov A.G., Delektor-skaya V.V., Kozlov N.A., Din S., Patutko U.I. Neuroendocrine pancreatic cancer: the results of surgical treatment. Annaly khirurgii. 2017; 22 (3): 155-162. DOI: 10.18821/1560-9502-2017-22-3-155-162. (In Russian)
15. Liu W., Zhou J.G., Sun Y., Zhang L., Xing B.C. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis. Oncotarget. 2016; 7 (24): 37277-37287. DOI: 10.18632/oncotarget.8671.
16. Khoo E., O'Neill S., Brown E., Wigmore S.J., Harrison E.M. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases. HPB (Oxford). 2016; 18 (6): 485-493. DOI: 10.1016/j.hpb.2016.03.001. Epub 2016 Apr 20.
17. Nigri G., Petrucciani N., Ferla F., La Torre M., Aurello P., Ramacciato G. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies. Surgeon. 2015; 13 (2): 83-90. DOI: 10.1016/j.surge.2014.07.005.
Review
For citations:
Patyutko Yu.I., Podluzhny D.V., Kudashkin N.E., Polyakov A.N., Gluhov E.V., Solovieva O.N., Dudaev Z.A. Ensuring radical surgery for liver malignancies. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2018;23(4):118-125. (In Russ.) https://doi.org/10.16931/1995-5464.20184118-125
Views:
737
Email this article 